22 Nov SAHPRA announces results of onsite inspection at Emergent BioSolutions facility in Baltimore, Maryland
22 November 2021 In June 2021, SAHPRA communicated that South Africa would not accept any product or ingredients made at the Emergent BioSolutions facility in Baltimore, Maryland until the Inspectorate conducted an onsite/remote inspection. This facility manufactures a drug substance used in some doses of the...